Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-24T01:50:42.587Z Has data issue: false hasContentIssue false

Children in HIV/AIDS Clinical Trials: Still Vulnerable after All These Years

Published online by Cambridge University Press:  29 April 2021

Extract

“All things considered, I chose what was best for my children, or what I thought was best…” confessed Jean- Jacques Rousseau in 1782. What more can one expect from a parent or a professional entrusted with decisions about children? What Rousseau thought was “best” for each of his five infants, however, was to dispatch them to foundling homes in Paris, without even keeping a record of their birthdates, thus leaving them to an unknown but probably dismal fate.

Acting from moral and often legal obligations to protect vulnerable persons from harm and to enhance their welfare, adults daily make decisions about and for children. Professionals and policy makers fulfill their social responsibilities by creating and implementing policies and practices that enable children's caregivers to fulfill these same goals.

Type
Article
Copyright
Copyright © American Society of Law, Medicine and Ethics 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rousseau, Jean-Jacques, Confessions (Paris, 1964 [1782]). Quoted in Boswell, John, The Kindness of Strangers (New York: Vintage Books, 1990), pp. 1, 20-21 (fn 42).Google Scholar
Geison, Gerald L., “Pasteur's Work on Rabies: Re-examining the Ethical Issues”, Hastings Center Report, April 1978, pp. 26-33.Google Scholar
Katz, Jay, Experimentation with Human Subjects (New York: Russell Sage Foundation, 1972), pp. 633, 1010–17).Google Scholar
Department of Health and Human Services Rules and Regulations, 45 CFR 46: Subpart D-Additional Protections for Children Involved as Subjects in Research (March 8, 1983).Google Scholar
Shirkey, H. C., “Therapeutic Orphans”, journal of Pediatrics, Vol. 72 (1968): 119–20.Google ScholarPubMed
Public Law No. 97-414, 96 Stat. 2049 (1983).Google Scholar
Levine, Robert J., Ethics and Regulation of Clinical Research, 2nd Edition (New Haven: Yale University Press, 1988), p. 240.Google ScholarPubMed
Unicef, “Children and AIDS: An Impending Calamity” (New York: 1990), pp. 45.Google Scholar
Centers for Disease Control, “HIV/AIDS Surveillance”, July 1991, p. 5.Google Scholar
Department of Health and Human Services, Secretary's Work Group on Pediatric HIV Infection and Disease, “Final Report” (Washington: 1988), p. 7.Google Scholar
Secretary's Work Group on Pediatric HIV Infection and Disease, pp. 16, 18.Google Scholar
Institute of Medicine, The AIDS Research Program of the National Institutes of Health: Report of a Study (Washington, DC: 1991), p. 12.Google Scholar
Levine, Carol Dubler, Nancy Neveloff and Levine, Robert J., “Building a New Consensus: Ethical Principles and Policies for Clinical Research on HIV/AIDS”, IRB: A Review of Human Subjects Research, Vol. 13, Nos. 1–2 (January-April 1991), p. 14.Google Scholar
Nolan, Kathleen, “AIDS and Pediatric Research”, Evaluation Review, Vol. 14, No. 4 (October 1990), 465.Google Scholar
Quoted in Sari Staver, “Apply Adult HIV Drug Studies to Kids’ Care, Experts Urge”, American Medical News, September 22/29, 1989, p. 40.Google Scholar
Levine, R.J., p. 236.Google Scholar
Martin, Judith M. and Sacks, Henry S., “Do HIV-Infected Children in Foster Care Have Access to Clinical Trials of New Treatments?AIDS & Public Policy Journal, Vol. 5, No. 1 (1990), 38.Google Scholar
Sabol, Barbara J., letter to Sarmistha Hauger, M.D., Assistant Medical Director, New York State AIDS Institute, May 28, 1991.Google Scholar
See Levine, Dubler, and Levine, , p. 15 for a further discussion of the role of a child advocate.Google Scholar
Secretary's Work Group, p. 21.Google Scholar
Nolan, , pp. 471–72.Google Scholar
Ackerman, Terrence, “Protectionism and the New Research Imperative in Pediatric AIDS”, IRB: A Review of Human Subjects Research, Vol. 12, No. 5 (September/October 1990), p.2.Google Scholar
Nolan, , p. 474, Citing Charles Fried, Medical Experimentation: Personal Integrity and Social Policy (New York: Elsevier, 1974).Google Scholar
Kovacs, Andrea Frederick, Toni Church, Joseph Eller, Andrea Oxtoby, Margaret and Mascola, Laurence, “CD4 T-Lymphocyte Counts and Pneumocystis carinii Pneumonia in Pediatric HIV Infection”, JAMA, Vol. 265, No. 13 (April 3 , 1991), 1702.CrossRefGoogle Scholar
Levine, Dubler, and Levine, , p. 8.Google Scholar
See, for example, Prentice, Ernest D. Antonson, Dean L. Jameton, Andrew Graver, Benjamin and Sears, Thomas, “Case Study: Can Children Be Enrolled in a Placebo-Controlled Trial of Synthetic Growth Hormone?” IRB: A Review of Human Subjects Research, Vol. 11, No. 1 (January/February 1989), pp. 610.Google Scholar
National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group, “Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus Infection”, New England Journal of Medicine, Vol. 325, No. 2 (July 11 , 1991), 7380.Google Scholar
Freedman, Benjamin, “Equipoise and the Ethics of Clinical Research”, New England Journal of Medicine, Vol. 317, No. 3 (1987), 141–45.Google Scholar
Levine, Dubler, and Levine, , p. 6.Google Scholar
Litt, Iris, “Adolescent Medicine”, JAMA, Vol. 265, No. 23 (June 19 , 1991), 3100.Google ScholarPubMed
See, e.g., Melton, Gary, “Ethical and Legal Issues in Research and Intervention”, Journal of Adolescent Health Care, Vol. 10 (1989), 36S44S.Google Scholar
Ad Hoc Committee on Adolescents and HIV, New York State AIDS Advisory Council, “Illusions of Immortality: The Confrontation of Adolescence and AIDS”, New York, n.d. [1991], pp. 2933.Google Scholar
Levine, Dubler, and Levine, , p. 15.Google Scholar
“Romanian Halts AIDS Drug Test,” New York Times, October 30, 1990.Google Scholar
Office of Protection from Research Risks, Division of Human Subject Protections, “Findings and Required Actions Regarding Investigation of Noncompliance with HHS Regulations for the Protection of Human Subjects Involving the National Institutes of Health Intramural Research Program”, July 3, 1991. The author was a member of a panel of special consultants to OPRR during this investigation; the information presented here is drawn solely from OPRR's “Interim Report.”Google Scholar
Geison, , p. 32.Google Scholar